| Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis JA Arosh, JH Lee, D Balasubbramanian, JA Stanley, CR Long, ... Proceedings of the National Academy of Sciences 112 (31), 9716-9721, 2015 | 86 | 2015 |
| Enhancing renal lymphatic expansion prevents hypertension in mice CA Lopez Gelston, D Balasubbramanian, GR Abouelkheir, AH Lopez, ... Circulation research 122 (8), 1094-1101, 2018 | 66 | 2018 |
| Kidney-specific lymphangiogenesis increases sodium excretion and lowers blood pressure in mice D Balasubbramanian, G Baranwal, MCC Clark, BL Goodlett, BM Mitchell, ... Journal of hypertension 38 (5), 874-885, 2020 | 29 | 2020 |
| Augmenting renal lymphatic density prevents angiotensin II-induced hypertension in male and female mice D Balasubbramanian, CAL Gelston, AH Lopez, G Iskander, W Tate, ... American journal of hypertension 33 (1), 61-69, 2020 | 29 | 2020 |
| Immune cell trafficking, lymphatics and hypertension D Balasubbramanian, CA Lopez Gelston, JM Rutkowski, BM Mitchell British Journal of Pharmacology 176 (12), 1978-1988, 2019 | 24 | 2019 |
| Toll-like receptor activation, vascular endothelial function, and hypertensive disorders of pregnancy D Balasubbramanian, CAL Gelston, BM Mitchell, P Chatterjee Pharmacological Research 121, 14-21, 2017 | 22 | 2017 |
| Is IL-12 pro-inflammatory or anti-inflammatory? Depends on the blood pressure D Balasubbramanian, BL Goodlett, BM Mitchell Cardiovascular research 115 (6), 998-999, 2019 | 19 | 2019 |
| A kidney-targeted nanoparticle to augment renal lymphatic density decreases blood pressure in hypertensive mice BL Goodlett, CS Kang, E Yoo, S Navaneethabalakrishnan, ... Pharmaceutics 14 (1), 84, 2021 | 7 | 2021 |
| Lymphatics in cardiovascular Physiology D Balasubbramanian, BM Mitchell Cold Spring Harbor perspectives in medicine 12 (8), 2022 | 6 | 2022 |
| Genetically inducing renal lymphangiogenesis attenuates hypertension in mice BL Goodlett, D Balasubbramanian, S Navaneethabalakrishnan, SE Love, ... Clinical Science 136 (23), 1759-1772, 2022 | 4 | 2022 |
| Smooth Muscle‐Specific Deletion of Neuropilin‐1 Increases Vascular Contractility and Blood Pressure D Balasubbramanian, G Lambrinos, V Cristofaro, A Bigger‐Allen, B Wang, ... The FASEB Journal 36, 2022 | 1 | 2022 |
| High dose vardenafil blunts the hypertensive effects of toll-like receptor 3 activation during pregnancy D Balasubbramanian, S Dharani, M Tauseef, MA Khan, Z Rahman, ... Frontiers in Virology 1, 780298, 2021 | 1 | 2021 |
| Neuropilins as Cancer Biomarkers: A Focus on Neuronal Origin and Specific Cell Functions D Balasubbramanian, Y Gao, DR Bielenberg Biomarkers of the Tumor Microenvironment, 295-306, 2022 | | 2022 |
| Semaphorin‐3F Deletion Prevents Oral Carcinogenesis J Omari, A Almazyad, S Alfaris, D Balasubbramanian, D Colombo, Y Gao, ... The FASEB Journal 36, 2022 | | 2022 |
| Deletion of Neuropilin‐1 in the Epidermis Delays Wound Healing S Alfaris, A Almazyad, J Omari, Y Gao, D Balasubbramanian, ... The FASEB Journal 36, 2022 | | 2022 |
| Targeting Neuropilin‐2 in Lymphatic Malformation Y Gao, D Balasubbramanian, A Greene, H Chen, D Bielenberg The FASEB Journal 36, 2022 | | 2022 |
| Semaphorin-3F Suppresses Vascular Permeability and Inflammation Y Gao, D Li, D Balasubbramanian, A Almazyad, H Chen, D Briscoe, ... Circulation 144 (Suppl_1), A12522-A12522, 2021 | | 2021 |
| Abstract MP17: Neuropilin-1 Is A Novel Regulator Of Vascular Tone And Blood Pressure D Balasubbramanian, G Lambrinos, V Cristofaro, A Bigger-Allen, B Wang, ... Hypertension 78 (suppl_1), AMP17-AMP17, 2021 | | 2021 |
| Neuropilin-1 Regulates Vascular Smooth Muscle Cell Contractility and Blood Pressure D Balasubbramanian, G Lambrinos, V Cristofaro, A Bigger-Allen, B Wang, ... AMERICAN JOURNAL OF PATHOLOGY 191 (10 S), S5-S5, 2021 | | 2021 |
| Semaphorin-3F Inhibits Vascular Permeability During Acute Inflammation Y Gao, D Li, D Balasubbramanian, A Almazyad, H Chen, D Briscoe, ... AMERICAN JOURNAL OF PATHOLOGY 190 (12), S22-S22, 2020 | | 2020 |
